Patent ID: 8106172

Claim:
A pair of oligonucleotides for amplification of a target sequence of the genome of SARS coronavirus, said pair selected from the group consisting of: (a) a first oligonucleotide sequence of: SEQ ID NO:4: TAGTAGCTGT ACCGACTGGT TATGTT, or the complementary nucleotide sequence of SEQ ID NO:4, and a second oligonucleotide sequence of: SEQ ID NO:7: GAAGCTATTC GTCACGTTCG, or the complementary nucleotide sequence of SEQ ID NO:7; (b) a first oligonucleotide sequence of SEQ ID NO:3: TCCACCAGGT GACCAGTTTA AACATCTT, or the complementary nucleotide sequence of SEQ ID NO:3, and a second oligonucleotide sequence of SEQ ID NO:8: TGCGTGGATT GGCTTTGATG T, or the complementary nucleotide sequence of SEQ ID NO:8; (c) a first oligonucleotide sequence of SEQ ID NO:25: TTGGCATGGA AGTCACACCT T, or the complementary nucleotide sequence of SEQ ID NO:25, and a second oligonucleotide sequence of SEQ ID NO:29: CAGAACAAAC CCAAGGAAAT T, or the complementary nucleotide sequence of SEQ ID NO:29; and any combination thereof.